Effects of Normobaric Hypoxia and Different Exercise Modes on Blood Glucose Regulation in Overweight Adults
1 other identifier
interventional
13
1 country
1
Brief Summary
Obesity is a major global health issue and a primary risk factor for metabolic-related disorders. While physical inactivity is one of the main contributors to obesity, it is a modifiable risk factor with exercise training as an established, non-pharmacological treatment to prevent the onset of metabolic-related disorders, including obesity. Exposure to low-oxygen availability (hypoxia) via normobaric hypoxia (simulated altitude via reduced inspired oxygen fraction), termed hypoxic conditioning, in combination with exercise has been increasingly shown in the last decade to enhance blood glucose regulation and decrease body mass index, providing a feasible strategy to treat obesity. However, findings from studies investigating the potential for hypoxia to augment the exercise training response and subsequent metabolic health are equivocal. Notably, there is a lack of information regarding the optimal combination of exercise variables and hypoxic severity to enable an individualized and safe practice of exercising in a hypoxic environment. In the present randomized, single-blind, cross-over study, the investigators will investigate the effects of single-bout of different exercise modes under moderate hypoxia (FiO2, 16.5%). The investigators hypothesize that all exercises combined with hypoxia improve glucose homeostasis in overweight individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 13, 2022
CompletedFirst Posted
Study publicly available on registry
November 28, 2022
CompletedStudy Start
First participant enrolled
January 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedNovember 22, 2023
November 1, 2023
6 months
November 13, 2022
November 20, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Oral glucose tolerance test (glucose)
Change of plasma glucose concentration immediately post-exercise under different exercise modes
Change of fasting and postprandial plasma glucose concentrations compared to different exercise mode at immediately after exercise
Oral glucose tolerance test (insulin)
Change of plasma insulin concentration immediately post-exercise under different exercise modes
Change of fasting and postprandial plasma insulin concentrations compared to different exercise mode at immediately after exercise
Study Arms (2)
Moderate hypoxia
EXPERIMENTALThe participant will perform different exercise modes under moderate hypoxia (fraction oxygen: 16.5%). Blood samples immediately after exercise oral glucose tolerance test will be collected.
Control normoxia
OTHERThe participant will not perform any exercise under normoxia and moderate hypoxia. Blood samples of oral glucose tolerance test will be collected.
Interventions
The participants will perform low-intensity cycling exercise at 90% lactate threshold under moderate hypoxia
The participants will perform sprint interval cycling exercise at a load of 7.5% bodyweight under moderate hypoxia.
The participants will perform bodyweight exercises under moderate hypoxia.
Eligibility Criteria
You may qualify if:
- BMI is between 25-29 kg/m²
- Physical inactive (physical activity \<150 min/week)
- No known heart or metabolic diseases (such as Type 2 diabetes)
- Not currently taking any prescribed medication
- No reported musculoskeletal injuries recently
- Not exposed to hypoxia \>1000 m prior to the study
You may not qualify if:
- Impaired glucose tolerance (2 hour glucose: \>7.8 - 11.1 mmol/L)
- Type 2 diabetes mellitus
- Obstructive sleep apnea
- Chronic obstructive pulmonary disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Sports Institute of Malaysia
Kuala Lumpur, 57000, Malaysia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 13, 2022
First Posted
November 28, 2022
Study Start
January 3, 2023
Primary Completion
June 30, 2023
Study Completion
August 1, 2023
Last Updated
November 22, 2023
Record last verified: 2023-11